MECOM and acute myeloid leukemia: In contrast to these results, Yoshimi et al showed C57BL6 mice transplanted with Evi1-transduced bone marrow cells all developed AML (characterized by high percentage of blasts on BM smear, positive myeloid markers for leukemic cells, marked splenomegaly) and died within 6–11 months after BMT [12].